修改为:et al. Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-overexpressing/amplifed (HER2+) metastatic colorectal cancer (mCRC): Primary results from the multicenter, randomized, phase 2 DESTINY-CRC02 study. J Clin Oncol 2023...
2020 National Comprehensive Cancer Network(NCCN), All rights reserved. NCCN Guidelinesand this illustration may not be reproduced in any form without the express written permission of NCCN. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines?) Rectal Cancer Version 1.2021 — December 22, ...
evidence-based information provided by the National Comprehensive Cancer Network (NCCN) Guidelines, which arguably represent the most important advance in cancer care occurring in the last many decades. Personalized oncology also demands that clinicians present guideline information to each patient in ...
NCCN Clinical Practice Guidelines in Oncology: rectal cancer. Engstrom Paul F,Arnoletti Juan Pablo,Benson Al B,Chen Yi-Jen,Choti Michael A,Cooper Harry S,Covey Anne,Dilawari Raza A,Early Dayna S,Enzinger Peter C,Fakih Marwan G,Fleshman James,Fuchs Charles,Grem Jean L,Kiel Krystyna,Knol ...
NCCN Guidelines Version 2.2022 NCCN Guidelines Index Table of Contents Prevention and Treatment of Cancer-Related Infections Discussion *Lindsey Robert Baden, MD Chair Ф John N. Greene, MD Ф Þ Steven Pergam, MD, MPH Ф Þ Dana-Farber/Brigham and Women’s Cancer Moffitt Cancer Center Fred...
参考文献 1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Colon Cancer. Version 3.2022 2. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Rectal Cancer. Version 4.2022 3. FDA grants accelerated approval to tucatinib with trastuzumab for colorectal cancer. January 19...
PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer. N Engl J Med. 2022;386(25):2363-2376. doi:10.1056/NEJMoa2201445 15. NCCN. Clinical practice guidelines in oncology. Rectal cancers, version 1.2023. Accessed April 5, 2023. https://bit.ly/2IvzwBF...
4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。 5. 装配图网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
Vice chair of the Colon Cancer and Rectal Cancer NCCN Guidelines Panels and Member of the Hepatocellular Carcinoma and Biliary Tract Cancers NCCN Guidelines Panels The Madden Family Distinguished Professorship in Medical Oncology and Translational Research at UCSF, the Shorenstein Associate Director for Pr...
2024 年第 1 版直肠癌 NCCN 指南相较于 2023 年第 6 版的更新要点如下: ►总体描述更新内容 在转移性疾病的 dMMR/MSI-H 描述/标题中添加 POLE/POLD1 突变。 全文将「消融」更改为「热消融」。 REC-1 ►新增内容 无蒂息肉伴浸润性癌的治疗前检查:内窥镜超声(EUS)或盆腔 MRI。